The membrane complement regulatory protein CD59 promotes tumor growth and predicts poor prognosis in breast cancer

被引:30
|
作者
Ouyang, Qianwen [1 ,2 ,3 ,4 ,5 ]
Zhang, Long [3 ,4 ,6 ]
Jiang, Yizhou [2 ,3 ,4 ]
Ni, Xiaojian [2 ,3 ,4 ]
Chen, Sheng [2 ,3 ,4 ]
Ye, Fugui [7 ]
Du, Yiqun [4 ,8 ]
Huang, Liang [2 ,3 ,4 ]
Ding, Peipei [3 ,4 ,6 ]
Wang, Na [3 ]
Yang, Chaoqun [9 ]
Huang, Tianbao [10 ]
Sun, Yujing [3 ]
Li, Shan [2 ,3 ,4 ]
Xia, Yun [1 ]
Hu, Weiguo [3 ,4 ,6 ]
Luo, Rongcheng [2 ,5 ]
Shao, Zhiming [3 ,4 ,6 ]
机构
[1] Third Hosp Nanchang, China Jiangxi Prov Key Lab Breast Dis, Dept Breast Surg, Nanchang, Jiangxi, Peoples R China
[2] Fudan Univ, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200032, Peoples R China
[3] Fudan Univ, Inst Canc, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[4] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200032, Peoples R China
[5] Southern Med Univ, Ctr Canc, Tradit Chinese Med Integrated Hosp, 1838 Guangzhou N Ave, Guangzhou 510515, Guangdong, Peoples R China
[6] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China
[7] Fujian Med Univ, Union Clin Sch, Affiliated Union Hosp, Dept Gen Surg, Fuzhou, Fujian, Peoples R China
[8] Fudan Univ, Huashan Hosp, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[9] Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai 200032, Peoples R China
[10] Tongji Univ, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China
基金
中国国家自然科学基金;
关键词
MDA-MB-231-HM; CD59; tumor growth; breast cancer; poor prognosis; ESTROGEN-RECEPTOR; BINDING PROTEIN; EXPRESSION; IMMUNOTHERAPY; TRASTUZUMAB; APOPTOSIS; TARGET; CELLS; GENE; CREB;
D O I
10.3892/ijo.2016.3408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the most prevalent type of cancer among women. CD59, a membrane complement regulatory protein, has been demonstrated to be overexpressed in most solid tumors, where it facilitates tumor cell escape from complement surveillance. However, the role of CD59 in breast cancer growth and clinical prognosis is not fully revealed. To investigate the role of CD59 in breast cancer growth and prognostic significance, we knocked down CD59 in a breast cancer cell line that is highly metastatic to the lungs, MDA-MB-231-HM. Cell growth was measured in vitro and in vivo using a xenograft model. In addition, clinical data on a cohort of 120 patients with or without lung metastasis was analyzed based on CD59 expression, which was detected by immunohistochemistry. Knockdown of CD59 significantly inhibited MDA-MB-231-HM cell growth both in vitro and in vivo. An analysis of clinical data on 120 patients revealed that patients with CD59 overexpression may have a worse prognosis. CD59 may therefore be a prognostic biomarker for poor outcome in breast cancer patients.
引用
收藏
页码:2015 / 2024
页数:10
相关论文
共 50 条
  • [21] Health status of transgenic pigs expressing the human complement regulatory protein CD59
    Deppenmeier, Stefanie
    Bock, Oliver
    Mengel, Michael
    Niemann, Heiner
    Kues, Wilfried
    Lemme, Erika
    Wirth, Dagmar
    Wonigeit, Kurt
    Kreipe, Hans
    XENOTRANSPLANTATION, 2006, 13 (04) : 345 - 356
  • [22] EXPRESSION OF CD59, A HUMAN-COMPLEMENT SYSTEM REGULATORY PROTEIN, IN EXTRAEMBRYONIC MEMBRANES
    VANDERPUYE, OA
    LABARRERE, CA
    MCINTYRE, JA
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1993, 101 (04) : 376 - 384
  • [23] Glycation of the Complement Regulatory Protein CD59 Is a Novel Biomarker for Glucose Handling in Humans
    Ghosh, Pamela
    Vaidya, Anand
    Sahoo, Rupam
    Goldfine, Allison
    Herring, Neil
    Bry, Lynn
    Chorev, Michael
    Halperin, Jose A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (06): : E999 - E1006
  • [24] STRUCTURE OF A SOLUBLE, GLYCOSYLATED FORM OF THE HUMAN-COMPLEMENT REGULATORY PROTEIN CD59
    FLETCHER, CM
    HARRISON, RA
    LACHMANN, PJ
    NEUHAUS, D
    STRUCTURE, 1994, 2 (03) : 185 - 199
  • [25] Analysis of the level of mRNA expression of the membrane regulators of complement, Cd59, Cd55 and Cd46, in breast, cancer
    Rushmere, NK
    Knowlden, JM
    Gee, JMW
    Harper, ME
    Robertson, JF
    Morgan, BP
    Nicholson, RI
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (06) : 930 - 936
  • [26] IDENTITY OF THE SEGMENT OF HUMAN-COMPLEMENT C8 RECOGNIZED BY COMPLEMENT REGULATORY PROTEIN CD59
    LOCKERT, DH
    KAUFMAN, KM
    CHANG, CP
    HUSLER, T
    SODETZ, JM
    SIMS, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) : 19723 - 19728
  • [27] Glycation-inactivation of the complement regulatory protein CD59 links complement to the pathogenesis of vascular diabetic complications
    Kumrei, N
    Qin, X
    Goldfine, A
    Grubissich, L
    Halperin, J
    DIABETES, 2002, 51 : A159 - A159
  • [28] Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients
    Liu, Xinyu
    Wang, Qianshan
    Song, Siqi
    Feng, Manman
    Wang, Xiaoya
    Li, Ling
    Liu, Ying
    Shi, Chunying
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [29] Immune Protection of Retroviral Vectors Upon Molecular Painting with the Complement Regulatory Protein CD59
    Susanne Heider
    Sandra Kleinberger
    Feliks Kochan
    John A. Dangerfield
    Christoph Metzner
    Molecular Biotechnology, 2016, 58 : 480 - 488
  • [30] Generation and functional characterization of transgenic pigs expressing the human complement regulatory protein CD59
    Lorenz, RR
    Winkler, M
    Przemeck, M
    Loss, M
    Wiebe, K
    Hecker, JM
    Paul, D
    Kniesch, K
    Niemann, H
    XENOTRANSPLANTATION, 2001, 8 : 53 - 54